ClinicalTrials.gov
public full text
Public Domain
Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor
In this study, the investigators are looking at how people make decisions about reward-related items, both monetary and food related after taking either the dopamine agonist bromocriptine or the COMT inhibitor tolcapone, in healthy control subjects. Subjects will fill self-report questionnaires and undergo an MRI scan.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cognitive engagement induces area-specific fingerprints of dopamine, acetylcholine, serotonin, glutamate and GABA in prefrontal cortex and striatum#296481
- Neurobiological Substrate of Social Context on Cognitive Control in Drug Users#807849
- Comparison of DBS Targets in Obsessive-compulsive Disorder#865885
- Effect of mCPP on Cognitive Control, Appetite, and Neural Responses#1161914
- Neural Responses to Reward and Psychosis Dimensions.#1107335
Record · ID 1096056
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive